Ignite Creation Date:
2024-05-06 @ 7:11 PM
Last Modification Date:
2024-10-26 @ 3:02 PM
Study NCT ID:
NCT05921877
Status:
RECRUITING
Last Update Posted:
2023-06-27
First Post:
2023-06-16
Brief Title:
AMH and Functional Hypothalamic Amenorrhea
Sponsor:
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Organization:
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Study Overview
Official Title:
AMH May Not be a Good Index of Ovarian Reserve in Patients With Functional Hypothalamic Amenorrhea
Status:
RECRUITING
Status Verified Date:
2023-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
AMELIA
Brief Summary:
The purpose of this study is to analyze AMH levels in patients with prolonged FHA more than 2 years Based on previous studies we can assume that prolonged FHA may mimic a condition of primary hypogonadotropic hypogonadism due to a lasting interruption of gonadotropin release Furthermore after the resumption of the spontaneous menstrual cycle we will reanalyze AMH levels which we hypothesize to find higher If our hypotheses are confirmed correct we could support the thesis that AMH is not a good index of ovarian reserve in patients with functional hypothalamic amenorrhea
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None